Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-12-03

Clinical Trial Update: The Prevention and Treatment of Nausea Associated With Motion Sickness [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for prevention and treatment of nausea associated with motion sickness has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Repurposed Therapeutics, Inc. | Conditions: Motion Sickness | Phase 3 | Status: COMPLETED